The Goeckerman regimen for the treatment of moderate to severe psoriasis
- PMID: 23892536
- PMCID: PMC3735239
- DOI: 10.3791/50509
The Goeckerman regimen for the treatment of moderate to severe psoriasis
Abstract
Psoriasis is a chronic, immune-mediated inflammatory skin disease affecting approximately 2-3% of the population. The Goeckerman regimen consists of exposure to ultraviolet B (UVB) light and application of crude coal tar (CCT). Goeckerman therapy is extremely effective and relatively safe for the treatment of psoriasis and for improving a patient's quality of life. In the following article, we present our protocol for the Goeckerman therapy that is utilized specifically at the University of California, San Francisco. This protocol details the preparation of supplies, administration of phototherapy and application of topical tar. This protocol also describes how to assess the patient daily, monitor for adverse effects (including pruritus and burning), and adjust the treatment based on the patient's response. Though it is one of the oldest therapies available for psoriasis, there is an absence of any published videos demonstrating the process in detail. The video is beneficial for healthcare providers who want to administer the therapy, for trainees who want to learn more about the process, and for prospective patients who want to undergo treatment for their cutaneous disease.
References
-
- Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. The Journal of Investigative Dermatology. 2012. - PubMed
-
- H GW. The treatment of psoriasis. Northwest Med. 1925;24:229–230.
-
- Koo J, Lebwohl M. Duration of remission of psoriasis therapies. Journal of the American Academy of Dermatology. 1999;41:51–59. - PubMed
-
- Menter A, Cram DL. The Goeckerman regimen in two psoriasis day care centers. Journal of the American Academy of Dermatology. 1983;9:59–65. - PubMed
-
- Lee E, Koo J. Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. The Journal of Dermatological Treatment. 2005;16:102–107. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical